Glen Santangelo
Stock Analyst at Barclays
(2.33)
# 2,727
Out of 5,182 analysts
139
Total ratings
46.32%
Success rate
-2.58%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTEV Claritev | Initiates: Overweight | $28 | $24.93 | +12.31% | 1 | Apr 24, 2026 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $30 → $23 | $21.88 | +5.12% | 4 | Apr 8, 2026 | |
| PHAT Phathom Pharmaceuticals | Upgrades: Overweight | $16 → $18 | $12.01 | +49.88% | 3 | Mar 27, 2026 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $8.5 → $7 | $6.46 | +8.36% | 9 | Mar 26, 2026 | |
| PCRX Pacira BioSciences | Maintains: Equal-Weight | $27 → $25 | $24.44 | +2.29% | 7 | Mar 26, 2026 | |
| VTRS Viatris | Maintains: Overweight | $15 → $17 | $15.04 | +13.03% | 6 | Mar 24, 2026 | |
| ALVO Alvotech | Maintains: Underweight | $5 → $4 | $3.46 | +15.61% | 2 | Mar 24, 2026 | |
| PGNY Progyny | Maintains: Overweight | $29 → $23 | $18.60 | +23.66% | 6 | Mar 20, 2026 | |
| ALGN Align Technology | Upgrades: Overweight | $200 | $178.91 | +11.79% | 4 | Mar 17, 2026 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $25 → $29 | $27.41 | +5.80% | 7 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5.5 → $5.25 | $5.19 | +1.16% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $7 | $5.65 | +23.89% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $7.5 → $8 | $13.29 | -39.80% | 2 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $243 → $258 | $195.24 | +32.15% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $960 → $1,050 | $814.02 | +28.99% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $110 | $82.40 | +33.50% | 8 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $425 | $304.00 | +39.80% | 2 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $34 | $26.33 | +29.13% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $38 | $24.98 | +52.12% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $850 → $800 | $567.46 | +40.98% | 2 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $38 | $34.95 | +8.73% | 7 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $5.25 → $2.75 | $2.55 | +7.84% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $44.75 | +11.73% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $56 | $34.32 | +63.17% | 5 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $24 | $9.67 | +148.19% | 3 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $136 | $114.16 | +19.13% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $6.28 | +43.31% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $63.62 | +57.18% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $73.93 | +16.33% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $22.51 | +33.27% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $11.81 | +1.61% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $80.39 | +24.39% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $12.83 | +16.91% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $35.25 | +39.01% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $20.95 | +143.44% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $6.27 | +1,494.90% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $75.61 | -27.26% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $75 | $9.60 | +681.25% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $1.45 | +1,831.03% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $6.12 | +1,860.78% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.99 | +3,550.38% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $82.09 | - | 3 | Mar 17, 2021 |
Claritev
Apr 24, 2026
Initiates: Overweight
Price Target: $28
Current: $24.93
Upside: +12.31%
Amphastar Pharmaceuticals
Apr 8, 2026
Maintains: Equal-Weight
Price Target: $30 → $23
Current: $21.88
Upside: +5.12%
Phathom Pharmaceuticals
Mar 27, 2026
Upgrades: Overweight
Price Target: $16 → $18
Current: $12.01
Upside: +49.88%
Teladoc Health
Mar 26, 2026
Maintains: Equal-Weight
Price Target: $8.5 → $7
Current: $6.46
Upside: +8.36%
Pacira BioSciences
Mar 26, 2026
Maintains: Equal-Weight
Price Target: $27 → $25
Current: $24.44
Upside: +2.29%
Viatris
Mar 24, 2026
Maintains: Overweight
Price Target: $15 → $17
Current: $15.04
Upside: +13.03%
Alvotech
Mar 24, 2026
Maintains: Underweight
Price Target: $5 → $4
Current: $3.46
Upside: +15.61%
Progyny
Mar 20, 2026
Maintains: Overweight
Price Target: $29 → $23
Current: $18.60
Upside: +23.66%
Align Technology
Mar 17, 2026
Upgrades: Overweight
Price Target: $200
Current: $178.91
Upside: +11.79%
Hims & Hers Health
Mar 11, 2026
Maintains: Overweight
Price Target: $25 → $29
Current: $27.41
Upside: +5.80%
Mar 10, 2026
Maintains: Equal-Weight
Price Target: $5.5 → $5.25
Current: $5.19
Upside: +1.16%
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $8 → $7
Current: $5.65
Upside: +23.89%
Feb 24, 2026
Maintains: Underweight
Price Target: $7.5 → $8
Current: $13.29
Upside: -39.80%
Feb 24, 2026
Maintains: Overweight
Price Target: $243 → $258
Current: $195.24
Upside: +32.15%
Feb 18, 2026
Maintains: Overweight
Price Target: $960 → $1,050
Current: $814.02
Upside: +28.99%
Feb 18, 2026
Maintains: Overweight
Price Target: $118 → $110
Current: $82.40
Upside: +33.50%
Feb 13, 2026
Maintains: Overweight
Price Target: $400 → $425
Current: $304.00
Upside: +39.80%
Feb 11, 2026
Maintains: Overweight
Price Target: $24 → $34
Current: $26.33
Upside: +29.13%
Feb 11, 2026
Maintains: Overweight
Price Target: $63 → $38
Current: $24.98
Upside: +52.12%
Feb 5, 2026
Maintains: Overweight
Price Target: $850 → $800
Current: $567.46
Upside: +40.98%
Jan 30, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $34.95
Upside: +8.73%
Jan 22, 2026
Downgrades: Hold
Price Target: $5.25 → $2.75
Current: $2.55
Upside: +7.84%
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $44.75
Upside: +11.73%
Jan 9, 2026
Maintains: Overweight
Price Target: $58 → $56
Current: $34.32
Upside: +63.17%
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $9.67
Upside: +148.19%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $114.16
Upside: +19.13%
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $6.28
Upside: +43.31%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $63.62
Upside: +57.18%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $73.93
Upside: +16.33%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $22.51
Upside: +33.27%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $11.81
Upside: +1.61%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $80.39
Upside: +24.39%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $12.83
Upside: +16.91%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $35.25
Upside: +39.01%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $20.95
Upside: +143.44%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $6.27
Upside: +1,494.90%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $75.61
Upside: -27.26%
Oct 21, 2022
Assumes: Buy
Price Target: $75
Current: $9.60
Upside: +681.25%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $1.45
Upside: +1,831.03%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $6.12
Upside: +1,860.78%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $0.99
Upside: +3,550.38%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $82.09
Upside: -